Detalhe da pesquisa
1.
High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
Int J Cancer
; 144(12): 3031-3042, 2019 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536939
2.
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
Int J Cancer
; 138(1): 125-36, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26205347
3.
Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
Int J Cancer
; 135(12): 2950-61, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771510
4.
Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
Br J Haematol
; 167(5): 639-50, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25155625
5.
Lytic Induction Therapy against Epstein-Barr Virus-Associated Malignancies: Past, Present, and Future.
Cancers (Basel)
; 12(8)2020 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748879
6.
Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.
Front Oncol
; 9: 81, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30873380
7.
Autophagy-Dependent Reactivation of Epstein-Barr Virus Lytic Cycle and Combinatorial Effects of Autophagy-Dependent and Independent Lytic Inducers in Nasopharyngeal Carcinoma.
Cancers (Basel)
; 11(12)2019 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769432
8.
Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib.
Oncotarget
; 9(38): 25101-25114, 2018 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29861856
9.
Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epsteinâ»Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers.
Cancers (Basel)
; 10(12)2018 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30544928
10.
Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
Nat Commun
; 9(1): 4663, 2018 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405107
11.
Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
Viruses
; 9(11)2017 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29160853
12.
Induction of MAPK- and ROS-dependent autophagy and apoptosis in gastric carcinoma by combination of romidepsin and bortezomib.
Oncotarget
; 7(4): 4454-67, 2016 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683357
13.
Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies.
PLoS One
; 10(12): e0145994, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26717578
14.
Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
Mol Cancer Ther
; 12(5): 747-58, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23475956